MedTrace Logo

Effect of Gabapentin on Idiopathic Subjective Tinnitus

NCT00555776 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2009-01-06

No results posted yet for this study

Summary

The purpose of this study is to determine wether Gabapentin which is useful for treating neuropathic pains, is effective on idiopathic subjective tinnitus.

Conditions

  • Subjective Tinnitus

Interventions

DRUG

Gabapentin

Gabapentin, 600 mg bid for the first two weeks, increased to a maximum dose of 1800 mg per day during the next 6 weeks if necessary.

DRUG

placebo

placebo is given with the same definition as Gabapentin

Sponsors & Collaborators

  • Islamic Azad University of Mashhad

    lead OTHER

Principal Investigators

  • Mahboobeh Adami Dehkordi, MD · ENT department of Mashhad azad university of mashhad

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2008-04-30
Completion
2008-10-31

Countries

  • Iran

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00555776 on ClinicalTrials.gov